2024 journal article

MARCKS Inhibition Alters Bovine Neutrophil Responses to <i>Salmonella</i> Typhimurium

Biomedicines.

By: H. Conley  n, C. Brown n, T. Westerman*, J. Elfenbein * & M. Sheats  n

TL;DR: This study demonstrates that MARCKS inhibition attenuated STm-induced neutrophil adhesion and chemotaxis and enhanced neutrophil phagocytosis and respiratory burst in response to STm, the first report describing the role of MARCKS protein in neutrophil antibacterial responses. (via Semantic Scholar)
Source: ORCID
Added: February 22, 2024

Neutrophils are innate immune cells that respond quickly to sites of bacterial infection and play an essential role in host defense. Interestingly, some bacterial pathogens benefit from exuberant neutrophil inflammation. Salmonella is one such pathogen that can utilize the toxic mediators released by neutrophils to colonize the intestine and cause enterocolitis. Because neutrophils can aid gut colonization during Salmonella infection, neutrophils represent a potential host-directed therapeutic target. Myristoylated alanine-rich C-kinase substrate (MARCKS) is an actin-binding protein that plays an essential role in many neutrophil effector responses. We hypothesized that inhibition of MARCKS protein would alter bovine neutrophil responses to Salmonella Typhimurium (STm) ex vivo. We used a MARCKS inhibitor peptide to investigate the role of MARCKS in neutrophil responses to STm. This study demonstrates that MARCKS inhibition attenuated STm-induced neutrophil adhesion and chemotaxis. Interestingly, MARCKS inhibition also enhanced neutrophil phagocytosis and respiratory burst in response to STm. This is the first report describing the role of MARCKS protein in neutrophil antibacterial responses.